Finds selective inhibitors of ribonuclease P in Staphylococcus aureus, suggesting new treatment approaches.
. Thus, expanding assay-based screening into broader chemical space can reveal novel scaffolds as potential starting points for the development of selective inhibitors targeting an essential bacterial RNA processing enzyme.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: